Broad cellular components in microbes

Broad cellular components in microbes refers to a generalized category of therapeutic targets encompassing essential structural and functional elements of microorganisms, including bacteria, fungi, and parasites (ChEMBL Database). This classification typically includes the microbial cell wall, cytoplasmic membrane, and broad metabolic pathways that are distinct from those in human cells (Goodman & Gilman's The Pharmacological Basis of Therapeutics). Drugs targeting these components, such as polymyxins or polyene antifungals, often work by physically disrupting the membrane or inhibiting the assembly of complex structural polymers like peptidoglycan or ergosterol (StatPearls). Because these targets are often conserved across many species, agents hitting them frequently possess broad-spectrum activity. However, the non-specific nature of these interactions can lead to significant safety concerns, including toxicity to host tissues that share similar lipid or structural features, such as nephrotoxicity and neurotoxicity (PubMed, PMID: 27334668). In drug discovery databases, this term serves as a high-level descriptor for agents whose precise molecular target is either a complex assembly or not yet fully characterized at the single-protein level.

Other names

Microbial structural componentsMicrobial cell wall and membraneNon-specific microbial targetsPathogen-associated molecular patterns

Disruption of microbial cell membrane integrity, inhibition of cell wall synthesis, or non-specific denaturation of microbial proteins and nucleic acids.